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ABSTRACT
Traditional diagnostic methods used to detect American Tegumentary Leishmaniasis, such 
as histopathology using biopsy samples, culture techniques, and direct search for parasites, 
have low sensitivity and require invasive collection procedures. This study evaluates the 
efficiency of noninvasive sampling methods (swab) along with Polymerase Chain Reaction 
(PCR) for diagnosing American Tegumentary Leishmaniasis using skin and mucous 
samples from 25 patients who had tested positive for leishmaniasis. The outcome of the tests 
performance on swab samples was compatible with PCR results on biopsy samples. The 
findings have also shown that PCR-kDNA test is more efficient than PCR-HSP70 and qPCR 
tests (sensitivity of 92.3%, 40.7%, and 41%, respectively). Given the high sensitivity of the 
tests and the fact that the sampling method using swabs affords greater patient comfort and 
safety, it could be said that this method is a promising alternative to conventional biopsy-
based methods for the molecular diagnosis of leishmaniasis.
KEYWORDS: Tegumentary Leishmaniasis. Polymerase Chain Reaction. Swab. Leishmania 
braziliensis.
INTRODUCTION
American Tegumentary Leishmaniasis (ATL) is a disease caused by protozoan 
parasites of the genus Leishmania and transmitted by the bite of infected sand flies1. 
It is regarded by the World Health Organization as one of the five major endemic 
infectious parasitic diseases worldwide and occurs in 98 countries2, including 18 in 
the Americas. In 2013, 47,492 cases were notified in 16 American countries, of which 
78.8% (37,402 cases) occurred in Brazil and countries of the Andean subregion3.
The diagnosis of ATL consists of the detection of the parasite or a test that 
determines its presence in the infected host. The most frequently used tests are: 
direct search for parasites in lesions and Montenegro skin test (MST). MST measures 
hypersensibility reactions to injection of Leishmania antigen. Serological tests, 
such as indirect immunofluorescence (IF) and enzyme immunoassay (EIA), are 
not commonly used since they do not distinguish between present and previous 
infections and may provide inconsistent results, having a cross-reaction with other 
diseases, such as Chagas disease4,5. The detection of parasites by direct search 
methods and MST, which, along with clinical and epidemiological aspects of the 
lesion form the basis of ATL diagnoses, are recommended in public health centers6.
Currently-used laboratory tests have low sensitivity and operational drawbacks 
in endemic areas, since they often involve slow and laborious procedures7,8. 
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Polymerase chain reaction (PCR) affords high sensitivity 
and specificity, and it is considered a useful method for 
diagnosing Leishmania infection9 using clinical specimens, 
particularly biopsy samples. Although different molecular 
techniques have been evaluated for the diagnosis of LT, 
PCR is the main molecular technique used, as it presents 
advantages such as speed, sensitivity and high specificity 
when compared to conventional techniques based on direct 
research and culture9-12. Various target genes have been used 
for the genus or species-specific diagnosis of tegumentary 
leishmaniasis. However, despite having lower specificity 
than other genes, the most commonly used target gene is 
kDNA, due to the high copy number of kDNA minicircles 
(around 10,000 per cell). Furthermore, degenerate primers 
are widely used in PCR-kDNA assays, making possible to 
afford a reduction in specificity. Other genes such as ITS, 
HSP70 and glucose-6-phosphate dehydrogenase has also 
been used with variable sensitivity and specificity13-17. 
PCR is the most commonly used method for detecting 
Leishmania DNA in samples taken from skin lesions. An 
alternative method that reduces the risk of contamination, 
for it decreases sample handling, is real-time PCR (qPCR). 
However, this method is available in a limited number of 
research centers and it is not routinely used in ATL diagnosis. 
Real-time PCR with kDNA and HSP70 genes as targets is a 
promising method, not only for detecting Leishmania DNA, 
but also for differentiating Leishmania species in samples 
taken from skin lesions, using High Resolution Melting 
(HRM)18-20. Current methods used to diagnose ATL, such 
as parasite examinations, histopathology and molecular 
analysis, use samples taken by using invasive methods, 
mainly lesion biopsies21. Invasive sampling methods are 
difficult to perform in settings with limited resources and 
without specialized training22,23. Additionally, biopsies 
can often be delicate, uncomfortable and painful for the 
patient24, and may cause bleeding at the biopsy site. The 
majority of researches on the detection of Leishmania DNA 
focus on biopsy samples, and few studies have evaluated 
the use of swabs, a relatively noninvasive sampling method. 
Matsumoto et al.25, observed that PCR-based diagnoses of 
cutaneous leishmaniasis using different sampling methods 
(scraping, suction and biopsy) showed similar levels of 
sensitivity. Recently, a study of qPCR-based diagnoses 
performed on swab samples from patients with cutaneous 
leishmaniasis using 18S rDNA as a target, observed an 
overall sensitivity of 97.5% and specificity of 84%26. The 
findings have also shown that test sensitivity was greater 
than the one of tests performed on samples collected using 
aspiration and procedures that are more painful. 
Noninvasive sample with swab can be collected in 
rural areas and tested in central laboratories, thus ensuring 
efficient, accurate and reliable PCR amplification. The use 
of noninvasive sampling, along with sensitive and simple 
molecular analysis, can be a valuable tool for overcoming 
the challenges of diagnosing tegumentary leishmaniasis. 
Moreover, swab samples afford greater flexibility when it 
comes to storage, as samples can be transported and stored 
at room temperature or at 4 °C, or ever conserved for long 
periods at -20 °C26.
Based on a sample of patients treated at the Leishmaniasis 
Clinic of the Emílio Ribas Institute of Infectious Diseases, 
this study aims to evaluate the efficiency of PCR-based 
noninvasive methods for diagnosing ATL, by comparing 
the sensitivity and specificity of DNA detection in biopsy 
samples and swab samples, as well as measuring and 
comparing the effectiveness of different Leishmania DNA 
targets in detecting leishmaniasis on swab samples collected 
from cutaneous and mucosal lesions.
MATERIALS AND METHODS
Patients and Healthy Volunteers 
The study sample comprised 25 patients with 
leishmaniasis confirmed by PCR-kDNA assays performed 
on biopsy samples considered the gold standard test for 
leishmaniasis in our casuistic and who were attended at 
the Leishmaniasis Clinic of the Emílio Ribas Institute 
of Infectious Diseases of the Department of Health of 
the State of São Paulo (IIER, acronym in Portuguese), 
between December 2013 and March 2015. Included in 
this group were all patients referred for diagnosis of ATL 
in the study period and who agreed to participate in the 
study. The control group comprised 10 volunteers whose 
samples were collected from the intact nasal septum. This 
study was approved by the Ethics Committee of IIER 
(Nº 07801112.1.0000.0061 and Opinion Nº 326/644) and 
Research Ethics Committees of the Faculty of Medicine 
at University of São Paulo (Application Nº 069/14). All 
participants were informed about study procedures and 
signed an informed consent form.
Obtaining the biopsy 
Biopsies were performed to obtain a sample of 
cutaneous and/or mucosal lesions in accordance with the 
procedures established by the clinic. Two small biopsy 
samples (approximately 3 mm in size) were obtained: one 
for on-site routine histopathological examination at the 
hospital; and one for direct search, Leishmania culture, and 
PCR. Biopsies from patients with LC were taken from the 
margin of the lesion. 
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Swab samples
The samples of the cutaneous and mucosal lesions from 
patients were collected using a cotton swab, as described 
by Mimori et al.27 and Boggild et al.28, after removing any 
overlapping scabs or crusts with a moist gauze and cleaning 
the wound site and the surrounding area using ethanol 70%, 
the swab is rubbed in a clockwise direction over the lesion 
surface. Samples from nasal mucosa of healthy volunteers 
were collect by swab and performed for detection of DNA 
from Leishmania. 
DNA extraction
The tip of the swab was then cut with sterile scissors and 
immediately placed in 1.5 mL tubes containing 700 µL of 
100% ethanol, and subsequently stored at -20 °C prior to 
DNA extraction. Swab samples were initially centrifuged 
at 3,000 x g for five minutes, after which ethanol was 
discarded. DNA extraction was then performed using 
the QIAamp DNA Mini Kit (QIAGEN Inc., Germany) 
according to manufacturer’s instructions. The samples were 
quantified using a NanoDrop spectrophotometer (Thermo 
Fisher Scientific Inc., USA) and 50 ng of DNA were used 
to perform PCR for each target gene. Only samples found 
to have a ratio of absorbance at 260 and 280 nm between 
-1.6 and -2.0 were used.
Polymerase Chain Reaction with kinetoplast DNA 
(kDNA) minicircle
The primers kDNA 20 (5’-GG KAG GGG CGT TCT 
SCG AA-3’) and kDNA 22 (5’-SSS WCT ATW TTA ACA 
CAA CCC C-3’), described by Volpini et al.29, were used 
for the conserved region of the leishmania kinetoplast DNA 
(kDNA), which amplified the 120 bp fragments. The final 
volume of the reaction mixture was 20 µL: 11.1 µL H2O, 
0.8 µL 25 mM MgCl2, 0.75 µL of each primer (10 mM), 
0.2 µL Taq Polymerase (Thermo Fisher Scientific), 2.0 µL 
10 X buffer, 0.4 µL 10mM dNTPs, and 4.0 µL DNA sample. 
Amplification was performed in a Veriti® Thermal Cycler 
(Life Technologies, Carlsbad, California, USA). The 
cycling conditions comprised an initial denaturation step at 
94 ºC for four minutes, followed by 35 cycles at 94 ºC for 
one minute, 58 ºC for one minute, and 72 ºC for 30 seconds, 
and a final extension step at 72 ºC for five minutes.
Polymerase Chain Reaction to detect DNA using the 
target gene HSP70 (70 kDa heat shock protein)
The following leishmania-specific primers were used: 
F1E (5’- CCC TCG TGT CGG ACT TCT T-3’) and R1E 
(5’- CTC CGT CTG CTT GCT CTT G -3’), which amplified 
the 125 bp fragments. The final volume of the reaction 
mixture was 25 µL: 16.05 µL H2O, 1.5 µL 25mM MgCl2, 
1.5 µL (10 mM) of each of the primers F1E and R1E, 
0.2 µL Taq Polymerase (Thermo Fisher Scientific), 2.5 µL 
10X buffer, 0.75 µL 10mM dNTPs. and 1.0 µL DNA sample. 
Amplification was performed in a Veriti® Thermal Cycler 
(Life Technologies, Carlsbad, California, USA). Cycling 
conditions comprised an initial denaturation step at 94 ºC for 
two minutes, followed by 35 cycles at 94 ºC for 30 seconds, 
60 ºC for 30 seconds, and 72 ºC for 30 seconds, and a final 
extension step at 72 ºC for seven minutes.
Analysis of the PCR products 
PCR products were electrophoresed on 2% agarose 
gels at 80 volts for one hour (Biotools/M&B Laboratories, 
S. A., Uniscience of Brazil, São Paulo, Brazil). After 
staining the gel with a 0.5 ug/ml ethidium bromide solution, 
amplification was visualized under ultraviolet illumination 
using the MacroVue™ UV transilluminator (Pharmacia 
Biotech, Uppsala, Sweden) and photographed using with a 
Canon Powershot S215 digital camera (Canon, NY, USA). 
A 100 bp DNA ladder molecular weight marker (Invitrogen 
Life Technologies, São Paulo, Brazil) was used for fragment 
size determination.
Restriction Fragment Length Polymorphism Analysis 
of kDNA (PCR-RFLP)
kDNA reaction products were digested using the 
restriction enzyme HaeIII FastDigest® (Themo Fisher 
Scientific) in accordance with the manufacturer’s 
instructions: 10 µl of positive PCR products were digested at 
37 °C for five minutes with 10 U of the restriction enzyme, 
specific buffer and ultrapure water in final volume of 30 µl. 
The products obtained from this procedure were 
electrophoresed on 10% polyacrylamide gel and stained 
with ethidium bromide. According to Volpini et al.30, this 
technique affords differentiation between L. (V.) braziliensis 
and L. (L.) amazonensis that may otherwise be difficult to 
determine using cleavage pattern in samples infected with 
this species.
Polymerase Chain Reaction in Real Time (qPCR) 
using SYBR Green
This technique was performed using leishmania-specific 
primers F1E (5’- CCC TCG TGT CGG ACT TCT T-3’) and 
R1E (5’- CTC CGT CTG CTT GCT CTT G -3’). The final 
Boni et al.
Rev Inst Med Trop São Paulo. 2017;59:e38Page 4 of 7
volume of the real time PCR reaction mixture was 25 µL: 
10.5 µL H2O, 12.5 µL Mix (UBS), 0.5 µL (10 mM) of each 
of the primers, and 1.0 µL sample in 30 ng/µL concentration 
of DNA. Samples were analyzed in triplicate.
Reference Standards 
The reference standard was considered the result of the 
PCR-kDNA on biopsy samples, in comparison with results 
of tests conducted in the present study. The diagnosis of 
tegumentary leishmaniasis was confirmed when the above 
test yielded a positive result.
Statistical Analysis
Statistical analyses were performed using Fisher’s exact 
test and chi-square test using Epi Info® 7.2. The level of 
significance was set at p < 0.05. 
RESULTS
The study sample comprised 25 patients, 14 of whom 
were suspected of having mucosal leishmaniasis (ML), and 
11 suspected of having cutaneous leishmaniasis (CL). Four 
of the patients suspected of having mucosal leishmaniasis 
(28.6%) had a skin lesions history. A total of 27 samples 
were collected from these patients: 15 samples from patients 
suspected of having ML, and 12 from patients suspected of 
having CL. The total number of samples was greater than the 
total number of patients, because one of the patients suspected 
of having ML had nasal and oral mucosa lesions, and one 
of the patients suspected of having CL had more than one 
lesion. All patients tested positive by PCR-kDNA performed 
on biopsy samples and were thus diagnosed as having ATL. 
After confirming leishmaniasis, PCR-kDNA was 
performed on swab samples to determine the sensitivity 
of the diagnosis, yielded positive results in 25 samples 
and negative results in two samples. The sensitivity 
and specificity of the PCR assay was 92.6% and 80%, 
respectively, since there two samples from negative control 
patients (healthy volunteers) had positive results.
A comparison between swab samples and biopsy 
samples showed an agreement rate of 86.2%: PCR-kDNA 
testing yielded positives results in all 27 biopsy samples and 
25 swab samples (p = 0.11), as shown in Table 1. 
A separate analysis between ML and CL patients 
demonstrated positivity rates of 93.3% (14/15) and 91.7% 
(11/12), respectively. However, this difference was not 
statistically significant (p = 0.72). The analysis of HaeIII 
enzyme cleavage patterns of the 25 swab samples confirmed 
the presence of L. braziliensis (80 and 40 bp). 
PCR assays using HSP70 primers performed on 22 of 
25 biopsy samples yielded a positivity rate of 81.82%, or 
18 samples: 10 samples from patients suspected of having 
ML, and eight from patients suspected of having CL. All 
22 biopsy samples were PCR-kDNA positive.
PCR assays using HSP70 primers performed on the 
27 swab samples yielded 11 positive and 16 negative 
results. The sensitivity and specificity of this PCR assay 
was 40.7% and 100%, respectively. All samples from 
healthy volunteers were negative for the target gene 
HSP 70. A separate analysis between ML and CL patients 
demonstrated positivity rates of 26.6% (4/15) and 58.3% 
(7/12), respectively (p = 0.12).
One swab sample from a patient suspected of having CL 
tested negative with the PCR-kDNA assay and positive with 
the PCR-HSP70 assay. Fifteen of the 16 swab samples that 
tested negative in the PCR-HSP70 assay were PCR-kDNA 
positive and one was negative on both tests (p = 0.66). 
Regarding the PCR-HSP70, differences were found 
in 13 of the 22 samples (two of the biopsy samples tested 
negative and 11 tested positive) as shown in Table 2. In 
one patient suspected of having of ML and one suspected 
of having CL, the biopsy samples tested negative and the 
swab samples tested positive. Eleven patients tested positive 
in biopsy samples and negative in swab samples. However, 
when the biopsy samples collected from these patients 
were tested using PCR-kDNA, all tested positive: eight 
ML patients, and three CL patients. The differences found 
Table 1 - Results of the diagnostic tests of 27 samples 
from patients suspected of having American Tegumentary 
Leishmaniasis treated at the IIER, between December 2013 
and March 2015
Biopsy 
samples
Swab samples
Positive Negative Total
Positive 25 2 27
Negative 0 0 0
Total 25 2 27
Table 2 - Results of diagnostic tests with HSP70 primers 
performed on 22 biopsy samples and 22 swab samples 
from patients suspected of having American Tegumentary 
Leishmaniasis treated at the IIER, between December 2013 
and March 2015
PCR-HSP70 
Biopsy
PCR-HSP70 Swab
Positive Negative Total
Positive 7 11 18
Negative 2 2 4
Total 9 13 22
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between biopsy samples and swab samples using HSP70 
primers were not statistically significant (p = 0.55).
Regarding qPCR assays using HSP70 primers, 22 
biopsy samples yielded 12 positive and 10 negative results. 
All positive samples were consistent with the results of 
conventional PCR-HSP70 and PCR-kDNA also analyzing 
biopsy samples. However, six of the 10 negative samples, 
tested positive - by conventional PCR-HSP70 and PCR-
kDNA; three of which were from ML patients, and three 
from CL patients. The analysis shows that the conventional 
PCR-HSP70 is more efficient than qPCR-HSP70 when 
using biopsy samples (p = 0.02).
Quantitative qPCR assays performed on 27 swab 
samples yielded nine positive results and 18 negative results. 
The sensitivity of qPCR was 33.3%. Five of the nine positive 
samples (55.6%) tested negative using conventional PCR 
assay for the same target (Table 3), two of which were from 
CL patients and three from ML patients; while seven of the 
18 negative samples, tested positive using conventional 
PCR assay, four of which were from CL patients, and three 
from ML patients.
A comparison of the results obtained from swab samples 
and biopsy samples using qPCR assays found a quantitative 
difference. However, this difference was not statistically 
significant (p = 0.45). From 12 patients that tested positive 
using qPCR performed on biopsy samples, only five tested 
positive using assays performed on swab samples, three 
of which were ML patients and two were CL patients. In 
line with these findings, only seven of the 10 patients that 
tested negative using qPCR performed on biopsy samples, 
tested negative using assays performed on swab samples, 
of which five were ML patients and two were CL patients. 
Therefore, qPCR testing performed on biopsy and swab 
samples yielded different results in 10 of the 22 patients.
A separate analysis between ML and CL patients 
demonstrated positivity rates of 26.7% (4/15) and 41.7% 
(5/12) respectively, showing that the effectiveness of the 
test was the same regardless of the form of leishmaniasis 
(p = 0.44). 
The following levels of agreement were observed 
between the molecular tests: swab samples taken from 
ML patients 44% between PCR-kDNA and PCR-HSP70 
(p = 0.73), 40% between PCR-kDNA and qPCR (p = 0.73), 
and 72% between PCR-HSP70 and qPCR (p = 0.75); swab 
samples taken from CL patients 53,8% between PCR-kDNA 
and PCR-HSP70 (p = 0.5), 33,3% between PCR-kDNA 
and qPCR (p = 0.67), and 50% between PCR-HSP70 and 
qPCR (p = 0.69). 
DISCUSSION
The increased availability of molecular methods 
with high sensitivity and specificity, together with the 
development of less invasive sample collection methods, 
have opened the path to more efficient diagnosis and 
a greater understanding of infection with Leishmania 
spp. As such, molecular methods have emerged as the 
new “gold standard” for the diagnosis of cutaneous 
leishmaniasis7, and are particularly useful for forms of 
the disease that have low parasite loads, such as mucosal 
leishmaniasis30.
The present study assessed the efficiency of non-invasive 
diagnostic method – the use of a swab – for detecting 
Leishmania using PCR performed with kDNA and HSP70 
targets and qPCR to detect HSP70. The performance of 
tests on swab samples was compatible with that of PCR 
performed on biopsy samples for tegumentary leishmaniasis 
analyzed in this study. These results corroborate the findings 
of Boggild et al.28 and Ferreira et al.31, who analyzed the use 
of swabs for sample collection on human patients and dogs, 
respectively, suspected of having ML, and those of Mimori 
et al.27, who observed sensitivity of 93.8% in detection of 
five species of Leishmania spp. using PCR performed on 
swab samples from CL patients.
The main problem faced by this study was the low level 
of DNA recovery from the swabs; however, this sampling 
method proved to be particularly useful, since it is painless, 
easy to perform without the need for specially qualified 
personnel, and it can be performed in any setting. Unlike 
invasive methods, such as skin biopsies, swab sampling 
minimizes the risk of iatrogenic infections that may 
compromise diagnosis and patient recovery32.
The findings of this study show that the high efficiency 
of PCR performed with kDNA primers in the detection 
of parasites in swab samples affords the opportunity 
of noninvasive access to tissues, and it is a promising 
alternative to conventional methods both for ML and CL 
patients. Similar results were found by Figueroa et al.23 in 
ML patients, reinforcing the findings of the present study 
with respect to the good performance of this test.
Table 3 - Results of the conventional PCR and qPCR- with 
the same target performed on 27 swab samples from patients 
suspected of having American Tegumentary Leishmaniasis 
treated at the IIER, between December 2013 and March 2015
PCR-HSP70 qPCR-HSP70 
Positive Negative Total
Positive 4 7 11
Negative 5 11 16
Total 9 18 27
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The use of kDNA as an amplification target in 
swab samples demonstrated favorable results due to its 
abundance on Leishmania DNA spp., which, according 
to Mouttaki et al.33 is around 10,000 copies per parasite. 
However, false-positive results, due to extremely sensitive 
reactions, are a concern29. This study used degenerate 
primers that paired Leishmania kDNA sequences, which 
explains the low specificity achieved. 
False-positive results were observed in the application 
of HSP70 primers to swab samples, which confirms its 
low sensitivity. The erroneous results were confirmed by 
routine and molecular tests using other primers and biopsy 
results. A difference in the efficiency of this test was also 
found between ML and CL patients, with better results in 
CL patients. This finding could be explained by the fact that 
larger quantities of parasites are found in skin lesions than 
in mucosal lesions. Despite the low rates found in this study, 
protocols using alterations in nucleotide bases of HSP70 
coding sequences and different melting times, enable 
differentiation between species of Leishmania in molecular 
tests performed on biopsy samples20, which affords a rapid 
and effective treatment for the disease. 
PCR-kDNA was more efficient than the HSP70 ones 
which showed low sensitivity in swab samples. These findings 
confirm that primers targeting the parasite kinetoplast DNA, 
are more efficient than the ones from HSP70 gene sequence 
in swab samples. Once again, these findings are justified by 
the abundance, specificity and repetitive nature of kDNA18, 
which avoid false-negative results. The findings also show 
that the sensitivity of PCR using HSP70 primers was higher 
in biopsy samples than in swab samples, mainly in those 
from CL patients. This is explained by the low level of DNA 
recovery from swabs and the fact that this is a single copy gene 
of Leishmania34 and it is more prevalent in biopsy samples. 
The efficiency of qPCR using HSP70 primers was low in 
both swab samples and biopsy samples, but it was higher in 
the later one. The results show that conventional PCR was 
more efficient in the case of swab samples. These results 
diverge from the findings of a study conducted by Adams 
et al.26 of qPCR performed using 18S rDNA primers on 
swab samples collected from CL patients, which observed 
sensitivity and specificity of 98% and 84%, respectively, 
showing that this test had good applicability and accuracy. 
No statistically significant difference was found between 
the three tests with respect to the different forms of the 
disease. However, it is evident that for swab samples, 
PCR-kDNA test is more efficient than PCR-HSP70 and 
qPCR tests, while for biopsy samples, PCR-kDNA and 
PCR-HSP70 tests are more efficient than qPCR test.
The findings of this study show that skin and mucosal 
samples collected using a swab have a significant diagnostic 
potential for detection of ATL using PCR due to this test 
high positivity rates, which are equivalent to those obtained 
from biopsy samples using the same primers. The use of 
swabs has various applications in the molecular diagnosis 
of human and canine leishmaniasis31. 
Although the present study shows that noninvasive 
sampling for the diagnosis of leishmaniasis using PCR 
is satisfactory, further research is required using other 
primers. The findings also show that PCR-kDNA testing 
is more efficient than qPCR testing with HSP70 primers. 
Swab sampling affords numerous advantages over biopsy 
samples, such as lower costs, patient comfort and security, 
and ease of performance, which in turn reduces the need for 
highly qualified personnel for sample collection. 
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